A digital therapeutic intervention delivered through a video game-like interface shows promise in improving attention in children with attention deficit/hyperactivity disorder (ADHD), according to a study in The Lancet Digital Health.
As children diagnosed with attention-deficit/hyperactivity disorder transition into adolescence and young adulthood, primary care providers are missing the mark in monitoring them for several important health risks, a study warns.
The American Academy of Pediatrics (AAP) has updated its 2011 clinical practice guideline on the evaluation, diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD) in children from age four to 18 years old.
Boys with attention-deficit/hyperactivity disorder (ADHD) show changes in brain white matter (WM) after four months of treatment with methylphenidate (MPH), according to a new randomized controlled trial.
A meta-analysis recently published in The Lancet Psychiatry found that using medicinal cannabinoids to treat mental health disorders cannot be justified, due to a lack of evidence of effectiveness and known risks of the substances.
SAN DIEGO—People with binge eating disorder are at increased risk of suicidal ideation and suicide attempt—and that risk appears even greater if they also have attention-deficit/hyperactivity disorder or have had bariatric surgery.
Children who have a parent in prison may be more than twice as likely as other kids to have depression, attention problems and conduct disorders by the time they reach adolescence, a U.S. study suggests.
The combined results of 61 studies conducted in 19 countries suggest that when a woman gives birth by cesarean section, autism in the child is 33% more likely and the odds of attention-deficit/hyperactivity disorder (ADHD) increase by 17%.
When a patient is newly diagnosed with attention-deficit/hyperactivity disorder (ADHD), is it better to begin treatment with a stimulant or a nonstimulant? Anthony L. Rostain, MD, MA, shares his thoughts in this video.